NIH – National Institute On Drug Abuse
UG1DA013720
Schmidt, R. D., Horigian, V. E., Duan, R., Traynor, S. T., Davis, C. A., Gonzalez, S. T., Forney, D. J., Mandler, R., Del Rio, C., Metsch, L. R., & Feaster, D. J. (2024). Psychosocial Factors Linked to Uncontrolled Infection and Mortality among People Living with HIV Who Use Substances: A Latent Class Analysis. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04410-2
Columbia Affiliation:
Grants:
UG1DA013720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1007/s10461-024-04410-2
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment
Luo, S. X., Feaster, D. J., Liu, Y., Balise, R. R., Hu, M.-C., Bouzoubaa, L., Odom, G. J., Brandt, L., Pan, Y., Hser, Y.-I., VanVeldhuisen, P., Castillo, F., Calderon, A. R., Rotrosen, J., Saxon, A. J., Weiss, R. D., Wall, M., & Nunes, E. V. (2024). Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. JAMA Psychiatry, 81(1), 45. https://doi.org/10.1001/jamapsychiatry.2023.3596
Subjects:
Opioid-Related Disorders
(MeSH)
Buprenorphine
(MeSH)
Grants:
UG1DA013720
(NIH – National Institute On Drug Abuse)
UG1DA013714
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1001/jamapsychiatry.2023.3596
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link:
Record Created:
Tookes, H. E., Oxner, A., Serota, D. P., Alonso, E., Metsch, L. R., Feaster, D. J., Ucha, J., Suarez, E., Forrest, D. W., McCollister, K., Rodriguez, A., Kolber, M. A., Chueng, T. A., Zayas, S., McCoy, B., Sutherland, K., Archer, C., & Bartholomew, T. S. (2023). Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs. Trials, 24(1). https://doi.org/10.1186/s13063-023-07074-w
Columbia Affiliation:
Subjects:
Hepatitis C
(MeSH)
HIV Infections
(MeSH)
Opioid-Related Disorders
(MeSH)
Substance Abuse, Intravenous
(MeSH)
Grants:
UG1DA013720
(NIH – National Institute On Drug Abuse)
DP2DA053720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1186/s13063-023-07074-w
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Source Link:
Record Created:
Paschen‐Wolff, M., Greenfield, S. F., Kathryn McHugh, R., Burlew, K., Pavlicova, M., Choo, T., Barbosa‐Leiker, C., Ruglass, L. M., Mennenga, S., Rotrosen, J., Nunes, E. V., & Campbell, A. N. C. (2023). Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder. The American Journal on Addictions, 32(6), 584–592. Portico. https://doi.org/10.1111/ajad.13463
Subjects:
Grants:
UG1DA013714
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
U10DA015833
(NIH – National Institute On Drug Abuse)
U10DA013045
(NIH – National Institute On Drug Abuse)
UG1DA013732
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/ajad.13463
PMID:
DOI:
Journal:
Publication Date:
Data Source:
PubMed
Source Link:
Record Created:
Parish, C. L., Feaster, D. J., Pollack, H. A., Horigian, V. E., Wang, X., Jacobs, P., Pereyra, M. R., Drymon, C., Allen, E., Gooden, L. K., del Rio, C., & Metsch, L. R. (2023). Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey. JMIR Research Protocols, 12, e47548. https://doi.org/10.2196/47548
Columbia Affiliation:
Grants:
UG1DA013720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.2196/47548
PMID:
DOI:
Journal:
Publication Date:
Data Source:
PubMed
Record Created:
Odom, G. J., Brandt, L., Castro, C., Luo, S. X., Feaster, D. J., & Balise, R. R. (2023). Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values. PLOS ONE, 18(9), e0291248. https://doi.org/10.1371/journal.pone.0291248
Grants:
UG1DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1371/journal.pone.0291248
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Source Link:
Record Created:
Liu, J., Pan, Y., Nelson, M. C., Gooden, L. K., Metsch, L. R., Rodriguez, A. E., Tross, S., del Rio, C., Mandler, R. N., & Feaster, D. J. (2023). Strategies of Managing Repeated Measures: Using Synthetic Random Forest to Predict HIV Viral Suppression Status Among Hospitalized Persons with HIV. AIDS and Behavior, 27(9), 2915–2931. https://doi.org/10.1007/s10461-023-04015-1
Subjects:
HIV Infections
(MeSH)
Grants:
P30AI073961
(NIH – National Institute of Allergy and Infectious Diseases)
P30MH116867
(NIH – National Institute of Mental Health)
P30MH133399
(NIH – National Institute of Mental Health)
UG1DA013732
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013727
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
UG1DA020024
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
U10DA020036
(NIH – National Institute On Drug Abuse)
UG1DA015815
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1007/s10461-023-04015-1
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link:
Record Created:
Schmidt, R. D., Horigian, V. E., Shmueli-Blumberg, D., Hefner, K., Feinberg, J., Kondapaka, R., Feaster, D. J., Duan, R., Gonzalez, S., Davis, C., Vena, A., Marín-Navarrete, R., & Tross, S. (2023). High suicidality predicts overdose events among people with substance use disorder: A latent class analysis. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1150062
Subjects:
Suicide
(MeSH)
Substance-Related Disorders
(MeSH)
Suicidal Behavior and Prevention Strategies
(OpenAlex Topic)
Epidemiology and Interventions for Substance Use Disorders
(OpenAlex Topic)
Impact of Stigma on Mental Health Care
(OpenAlex Topic)
Grants:
U54GM104942
(NIH – National Institute of General Medical Sciences)
UG1DA013035
(NIH – National Institute On Drug Abuse)
UG1DA049436
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.3389/fpubh.2023.1150062
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link:
Record Created:
Serota, D. P., Rosenbloom, L., Hervera, B., Seo, G., Feaster, D. J., Metsch, L. R., Suarez, E., Chueng, T. A., Hernandez, S., Rodriguez, A. E., Tookes, H. E., Doblecki-Lewis, S., & Bartholomew, T. S. (2022). Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control. Open Forum Infectious Diseases, 10(1). https://doi.org/10.1093/ofid/ofac688
Columbia Affiliation:
Grants:
UG1DA013720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1093/ofid/ofac688
PMID:
DOI:
Journal:
Publication Date:
Data Source:
PubMed
Record Created:
Bunting, A. M., Krawczyk, N., Choo, T.-H., Pavlicova, M., McNeely, J., Tofighi, B., Rotrosen, J., Nunes, E., & Lee, J. D. (2022). Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes. Journal of Substance Abuse Treatment, 143, 108830. https://doi.org/10.1016/j.jsat.2022.108830
Subjects:
Narcotic Antagonists
(MeSH)
Opioid-Related Disorders
(MeSH)
Grants:
T32HS026120
(NIH – Agency for Healthcare Research and Quality)
UG1DA013732
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
U10DA013714
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
U10DA013035
(NIH – National Institute On Drug Abuse)
U10DA013720
(NIH – National Institute On Drug Abuse)
R25DA037190
(NIH – National Institute On Drug Abuse)
U10DA015831
(NIH – National Institute On Drug Abuse)
U10DA013045
(NIH – National Institute On Drug Abuse)
U10DA013034
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
K23DA042140
(NIH – National Institute On Drug Abuse)
UG1DA013714
(NIH – National Institute On Drug Abuse)
U10DA015833
(NIH – National Institute On Drug Abuse)
U10DA013732
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
K01DA053435
(NIH – National Institute On Drug Abuse)
U10DA013046
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1016/j.jsat.2022.108830
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Record Created:
Na, P. J., Scodes, J., Fishman, M., Rotrosen, J., & Jr, E. V. N. (2022). Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder. The Journal of Clinical Psychiatry, 83(3). https://doi.org/10.4088/jcp.21m14140
Subjects:
Grants:
UG1DA013034
(NIH – National Institute On Drug Abuse)
U10DA013732
(NIH – National Institute On Drug Abuse)
UG1DA013732
(NIH – National Institute On Drug Abuse)
U10DA015833
(NIH – National Institute On Drug Abuse)
UG1DA013714
(NIH – National Institute On Drug Abuse)
U10DA013714
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
U10DA013720
(NIH – National Institute On Drug Abuse)
U10DA013034
(NIH – National Institute On Drug Abuse)
K24DA022412
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
U10DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
U10DA015831
(NIH – National Institute On Drug Abuse)
U10DA013045
(NIH – National Institute On Drug Abuse)
U10DA013046
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.4088/JCP.21m14140
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Tookes, H., Ucha, J., Rodriguez, A. E., Suarez, E., Alonso, E., Metsch, L. R., Feaster, D. J., Bartholomew, T. S., Hoffman, K. A., & Korthuis, P. T. (2021). Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study. The Journal of Behavioral Health Services & Research, 49(2), 240–251. https://doi.org/10.1007/s11414-021-09771-3
Columbia Affiliation:
Subjects:
Grants:
UG1DA013720
(NIH – National Institute On Drug Abuse)
R01DA045713
(NIH – National Institute On Drug Abuse)
UG1DA015815
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1007/s11414-021-09771-3
PMID:
Publication Date:
Data Source:
Scopus
Record Created:
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs
Gutkind, S., Starbird, L. E., Murphy, S. M., Teixeira, P. A., Gooden, L. K., Matheson, T., Feaster, D. J., Jain, M. K., Masson, C. L., Perlman, D. C., Del Rio, C., Metsch, L. R., & Schackman, B. R. (2022). Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs. Drug and Alcohol Dependence, 232, 109265. https://doi.org/10.1016/j.drugalcdep.2022.109265
Columbia Affiliation:
Subjects:
Grants:
P30AI073961
(NIH – National Institute of Allergy and Infectious Diseases)
P30AI050409
(NIH – National Institute of Allergy and Infectious Diseases)
T32NR014205
(NIH – National Institute of Nursing Research)
UG1DA020024
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
UG1DA015815
(NIH – National Institute On Drug Abuse)
P30DA040500
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
P30DA011041
(NIH – National Institute On Drug Abuse)
T32DA031099
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
K01DA051348
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2022.109265
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Roache, J. D., Pavlicova, M., Campbell, A., Choo, T., Peavy, M., Kermack, A. S., Nunes, E. V., & Rotrosen, J. (2021). Is extended release naltrexone superior to buprenorphine‐naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcoholism: Clinical and Experimental Research, 45(12), 2569–2578. Portico. https://doi.org/10.1111/acer.14729
Subjects:
Grants:
UG1DA013034
(NIH – National Institute On Drug Abuse)
U10DA015833
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
UG1DA013714
(NIH – National Institute On Drug Abuse)
UG1DA013732
(NIH – National Institute On Drug Abuse)
K24DA022412
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
U10DA013035
(NIH – National Institute On Drug Abuse)
U10DA013045
(NIH – National Institute On Drug Abuse)
U10DA013046
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/acer.14729
PMID:
DOI:
Publication Date:
Data Source:
Scopus
Record Created:
Murphy, S. M., Jeng, P. J., McCollister, K. E., Leff, J. A., Jalali, A., Shulman, M., Lee, J. D., Nunes, E. V., Novo, P., Rotrosen, J., & Schackman, B. R. (2021). Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. Addiction (Abingdon, England), 116(12), 3444–3453. https://doi.org/10.1111/add.15531
Subjects:
Naltrexone
(MeSH)
Opioid-Related Disorders
(MeSH)
Grants:
K24DA022412
(NIH – National Institute On Drug Abuse)
U10DA013045
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
P30DA040500
(NIH – National Institute On Drug Abuse)
U10DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
UG1DA013732
(NIH – National Institute On Drug Abuse)
R01DA035808
(NIH – National Institute On Drug Abuse)
U10DA015833
(NIH – National Institute On Drug Abuse)
U10DA013732
(NIH – National Institute On Drug Abuse)
U10DA013034
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
UG1DA013714
(NIH – National Institute On Drug Abuse)
U10DA015831
(NIH – National Institute On Drug Abuse)
U10DA013714
(NIH – National Institute On Drug Abuse)
U10DA013720
(NIH – National Institute On Drug Abuse)
U10DA013046
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/add.15531
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial
Fishman, M., Wenzel, K., Scodes, J., Pavlicova, M., Campbell, A. N. C., Rotrosen, J., & Nunes, E. (2021). Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial. The American Journal on Addictions, 30(5), 433–444. Portico. https://doi.org/10.1111/ajad.13176
Subjects:
Grants:
R61AT010614
(NIH – National Center for Complementary & Integrative Health)
U10DA015831
(NIH – National Institute On Drug Abuse)
U10DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
U10DA013714
(NIH – National Institute On Drug Abuse)
U10DA013720
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
UG1DA013732
(NIH – National Institute On Drug Abuse)
UG1DA013714
(NIH – National Institute On Drug Abuse)
U10DA013732
(NIH – National Institute On Drug Abuse)
U10DA013045
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
U10DA013034
(NIH – National Institute On Drug Abuse)
U10DA015833
(NIH – National Institute On Drug Abuse)
UG1DA015831
(NIH – National Institute On Drug Abuse)
U10DA013046
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/ajad.13176
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Nunes, E. V., Scodes, J. M., Pavlicova, M., Lee, J. D., Novo, P., Campbell, A. N. C., & Rotrosen, J. (2021). Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment. American Journal of Psychiatry, 178(7), 660–671. https://doi.org/10.1176/appi.ajp.2020.20060816
Columbia Affiliation:
Subjects:
Delayed-Action Preparations
(MeSH)
Naltrexone
(MeSH)
Narcotic Antagonists
(MeSH)
Opioid-Related Disorders
(MeSH)
Grants:
UG1DA015831
(NIH – National Institute On Drug Abuse)
U10DA013045
(NIH – National Institute On Drug Abuse)
U10DA013720
(NIH – National Institute On Drug Abuse)
UG1DA013035
(NIH – National Institute On Drug Abuse)
UG1DA013714
(NIH – National Institute On Drug Abuse)
U10DA015831
(NIH – National Institute On Drug Abuse)
K24DA022412
(NIH – National Institute On Drug Abuse)
U10DA013035
(NIH – National Institute On Drug Abuse)
U10DA015833
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
UG1DA013732
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
U10DA013732
(NIH – National Institute On Drug Abuse)
U10DA013714
(NIH – National Institute On Drug Abuse)
U10DA013034
(NIH – National Institute On Drug Abuse)
U10DA013046
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1176/appi.ajp.2020.20060816
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Traynor, S. M., Metsch, L. R., Gooden, L., Stitzer, M., Matheson, T., Tross, S., Carrico, A. W., Jain, M. K., del Rio, C., & Feaster, D. J. (2021). Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use. Drug and Alcohol Dependence, 221, 108567. https://doi.org/10.1016/j.drugalcdep.2021.108567
Subjects:
HIV Infections
(MeSH)
Patient Navigation
(MeSH)
Self Efficacy
(MeSH)
Substance-Related Disorders
(MeSH)
Grants:
U10DA013720
(NIH – National Institute On Drug Abuse)
UG1DA013034
(NIH – National Institute On Drug Abuse)
UG1DA013720
(NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2021.108567
PMID:
Journal:
Publication Date:
Data Source:
Scopus